149 related articles for article (PubMed ID: 3680465)
1. Analgesic use, blood dyscrasias, and case-control pharmacoepidemiology. A critique of the International Agranulocytosis and Aplastic Anemia Study.
Kramer MS; Lane DA; Hutchinson TA
J Chronic Dis; 1987; 40(12):1073-85. PubMed ID: 3680465
[TBL] [Abstract][Full Text] [Related]
2. Drugs in the aetiology of agranulocytosis and aplastic anaemia.
Kaufman DW; Kelly JP; Jurgelon JM; Anderson T; Issaragrisil S; Wiholm BE; Young NS; Leaverton P; Levy M; Shapiro S
Eur J Haematol Suppl; 1996; 60():23-30. PubMed ID: 8987237
[TBL] [Abstract][Full Text] [Related]
3. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study.
JAMA; 1986 Oct; 256(13):1749-57. PubMed ID: 3747087
[TBL] [Abstract][Full Text] [Related]
4. Analgesic risks and pharmacoepidemiology.
Faich GA
JAMA; 1986 Oct; 256(13):1788. PubMed ID: 3747091
[No Abstract] [Full Text] [Related]
5. Risk of agranulocytosis and aplastic anemia in relation to history of infectious mononucleosis: a report from the international agranulocytosis and aplastic anemia study.
Levy M; Kelly JP; Kaufman DW; Shapiro S
Ann Hematol; 1993 Oct; 67(4):187-90. PubMed ID: 8218540
[TBL] [Abstract][Full Text] [Related]
6. Scientific standards and the design of case-control research.
Imperiale TF; Horwitz RI
Biomed Pharmacother; 1989; 43(3):187-96. PubMed ID: 2775855
[TBL] [Abstract][Full Text] [Related]
7. Risks of agranulocytosis and aplastic anemia in relation to the use of cardiovascular drugs: The International Agranulocytosis and Aplastic Anemia Study.
Kelly JP; Kaufman DW; Shapiro S
Clin Pharmacol Ther; 1991 Mar; 49(3):330-41. PubMed ID: 1672513
[TBL] [Abstract][Full Text] [Related]
8. The International Agranulocytosis and Aplastic Anemia Study (IAAAS).
Kramer MS; Lane DA; Hutchinson TA
J Clin Epidemiol; 1988; 41(6):613-6. PubMed ID: 3290398
[No Abstract] [Full Text] [Related]
9. Drug-related blood dyscrasias in a Swedish reporting system, 1985-1994.
Wiholm BE; Emanuelsson S
Eur J Haematol Suppl; 1996; 60():42-6. PubMed ID: 8987240
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia, agranulocytosis and dipyrone.
Hamerschlak N; Cavalcanti AB
Sao Paulo Med J; 2005 Sep; 123(5):247-9. PubMed ID: 16358101
[TBL] [Abstract][Full Text] [Related]
11. Analgesics, agranulocytosis, and aplastic anaemia: a major case-control study.
Lancet; 1986 Oct; 2(8512):899-900. PubMed ID: 2876332
[No Abstract] [Full Text] [Related]
12. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
Eur J Clin Pharmacol; 1983; 24(6):833-6. PubMed ID: 6884419
[No Abstract] [Full Text] [Related]
13. Anti-infective drug use in relation to the risk of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study.
Arch Intern Med; 1989 May; 149(5):1036-40. PubMed ID: 2785785
[TBL] [Abstract][Full Text] [Related]
14. Relative incidence of agranulocytosis and aplastic anemia.
Kaufman DW; Kelly JP; Issaragrisil S; Laporte JR; Anderson T; Levy M; Shapiro S; Young NS
Am J Hematol; 2006 Jan; 81(1):65-7. PubMed ID: 16369972
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced blood dyscrasias. A ten-year material from the Swedish Adverse Drug Reaction Committee.
Böttiger LE; Furhoff AK; Holmberg L
Acta Med Scand; 1979; 205(6):457-61. PubMed ID: 452939
[TBL] [Abstract][Full Text] [Related]
16. Analgesics, agranulocytosis, and aplastic anaemia.
Doll R; Lunde PK; Moeschlin S
Lancet; 1987 Jan; 1(8524):101. PubMed ID: 2879151
[No Abstract] [Full Text] [Related]
17. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: incidence and associations with antecedent prescription drug use.
Rawson NS; Harding SR; Malcolm E; Lueck L
J Clin Epidemiol; 1998 Dec; 51(12):1343-55. PubMed ID: 10086829
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced blood dyscrasias in Sweden.
Böttiger LE; Westerholm B
Br Med J; 1973 Aug; 3(5875):339-43. PubMed ID: 4723818
[TBL] [Abstract][Full Text] [Related]
19. Aplastic anemia and agranulocytosis in patients using methazolamide for glaucoma.
Werblin TP; Pollack IP; Liss RA
JAMA; 1979 Jun; 241(26):2817-8. PubMed ID: 448845
[TBL] [Abstract][Full Text] [Related]
20. Risk of agranulocytosis and aplastic anaemia in relation to use of antithyroid drugs. International Agranulocytosis and Aplastic Anaemia Study.
BMJ; 1988 Jul; 297(6643):262-5. PubMed ID: 2458161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
